ID: ALA5273529

Max Phase: Preclinical

Molecular Formula: C19H24O3

Molecular Weight: 300.40

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)/C=C/C(C)=C/c1ccc2c(c1)CCC(C)(C)O2

Standard InChI:  InChI=1S/C19H24O3/c1-5-21-18(20)9-6-14(2)12-15-7-8-17-16(13-15)10-11-19(3,4)22-17/h6-9,12-13H,5,10-11H2,1-4H3/b9-6+,14-12+

Standard InChI Key:  MFFZYNFONVFRDW-TZOAMJEDSA-N

Associated Targets(non-human)

Quinolone resistance protein norA 2171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.40Molecular Weight (Monoisotopic): 300.1725AlogP: 4.31#Rotatable Bonds: 4
Polar Surface Area: 35.53Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.67CX LogD: 4.67
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.47Np Likeness Score: 0.83

References

1. Kumar G, Kiran Tudu A..  (2023)  Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors.,  80  [PMID:36731248] [10.1016/j.bmc.2023.117187]

Source